$31.99 0.09 (+0.28%)
2/13/2012 4:00 PM

Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

6
Player Avatar BringUs (31.97) Submitted: 5/4/2009 12:43:43 PM : Outperform Start Price: $17.11 BMY Score: +34.60

The insiders are buying. The dividend is fat. They haven't eaten up another company like their bio/pharma bretheren (think PFE, MRK, Roche), so they don't have any rocky integrations to worry about. They have a stocked pipeline ( http://www.bms.com/research/pipeline/Pages/default.aspx).
Plus, we have a 1995 sale price. If you ever wanted to go back in time, well...

Report this Post Add Comment

Featured Broker Partners


Advertisement